Kaplan Publishing, a leading publisher of academic and professional development resources, has partnered with Kno, a leading education software provider, to bring e-books to medical school students and doctors studying for the United States Medical Licensing Examination. The USMLE, divided into Steps 1, 2 and 3, is taken by tens of thousands of aspiring doctors annually as a requirement to practice medicine in the United States.
The titles included for the Kaplan/Kno partnership are MedEssentials, USMLE Step 1 Microbiology/Immunology, USMLE Step 1 Pharmacology, USMLE Step 2 Internal Medicine, and USMLE Step 2 Surgery.
A recent survey of Kaplan students showed that 97% report owning a tablet device, electronic reader or smartphone. In the survey, students noted the value of portability from print to digital and across devices, accessibility and offline access in their e-books. Noted one student, “It’s nice to have all these books on one small device,” while another observed, “Constant access is useful.” The Kno eTextbooks enable students to carry all their reading on a single device, access their textbooks across many platforms and devices, and conduct their reading offline and on-the-go.
Yet despite students’ overwhelming adoption of smartphones and tablet devices, many still prefer to have the option of reading their books in the traditional print format -- with the majority of students surveyed indicating the desire for both options.“In an age of Wikipedia and Google, where an overwhelming amount of information is readily available, the key is not just in the right information, but in how it’s delivered. Students want choice in how they prepare for important exams like the USMLE,” said Maureen McMahon, president and publisher, Kaplan Publishing. “Students would ideally prefer to move seamlessly between print and digital formats. It’s important that we help students study in the formats that best meet their preferences and fall within their comfort zones.”
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV